BEIJING, Nov. 12, 2021 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), an agriculture technology company, today announced that its new GMO corn trait has finished its environmental release trials and is in preparations for production trials (the fourth stage in the five stage process to receive its bio-safety certificate). The… Read More..

Nearing full enrollment in ALS Phase 2 Study; topline data expected 1H 2022 Received Investigational New Drug (“IND”) clearance from the FDA for AT-1501 in islet cell transplantation in the U.S. Announced renal transplantation research collaboration with CareDx, Inc. Initiated AT-1501 monotherapy non-human primate renal transplant study; topline data expected… Read More..

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders, today announced that management will participate in a fireside chat at the Jefferies London Healthcare Conference. The presentation will be available for on-demand viewing starting Thursday,… Read More..